InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Atlas Venture Fund XII, L.P.. Director active across 2 companies, notably Aerovate Therapeutics, Inc.. Cumulatively, 5 disclosures have been recorded. Activity tracked since 1 April 2022. The latest transaction was disclosed on 15 July 2022 (J). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Atlas Venture Fund XII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
4,808,896 股Common StockSEC:0001415889-25-021282:0
310,388 股0Common StockSEC:0001209191-22-042614:0
465,582 股0Common StockSEC:0001209191-22-022540:0
2,831,520 股Common StockSEC:0000899243-22-001654:0
2,568,165 股Common StockSEC:0001104659-21-089434:0
5 条申报中的 5 条
About Atlas Venture Fund XII, L.P.
Atlas Venture Fund XII, L.P. is a director and insider, primarily involved with Aerovate Therapeutics, Inc. and Vigil Neuroscience, Inc.
